Clinical Trials on Antiphospholipid Syndrome: What is Being Done and What is Needed?
- 1 August 1994
- journal article
- review article
- Published by SAGE Publications in Lupus
- Vol. 3 (4), 303-307
- https://doi.org/10.1177/096120339400300419
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancerThe Lancet, 1994
- Influence of anticardiolipin antibodies on immediate patient outcome after myocardial infarction.Journal of Clinical Pathology, 1993
- Anticardiolipin antibodies in ischaemic heart disease: marker or myth?Heart, 1993
- Antiphospholipid antibodies and recurrent thrombo-occlusive eventsThe Lancet, 1992
- Stroke and Parkinson's disease.Stroke, 1992
- Antiphospholipid antibodies in patients with previous myocardial infarctionThe Lancet, 1992
- Granulocyte adhesion, deformability, and superoxide formation in acute stroke.Stroke, 1992
- Screening for lupus anticoagulant and anticardiolipin antibodies in women with fetal loss.Journal of Clinical Pathology, 1991
- Obstetric Complications Associated with the Lupus AnticoagulantNew England Journal of Medicine, 1985
- Antibody to Cardiolipin as a Predictor of Fetal Distress or Death in Pregnant Patients with Systemic Lupus ErythematosusNew England Journal of Medicine, 1985